- Title: Subtitle
- PREDICTIVE BLOOD-BASED BIOMARKERS IN CERVICAL CANCER PATIENTS TREATED WITH PACLITAXEL-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: RESULTS FROM GOG-0240
- Creators
- Angeles Alvarez Secord - Duke, Durham, United States of AmericaMichael Sill - Roswell Park, Biostatistics And Bioinformatics, Roswell, United States of AmericaHeather Lankes - NRG Statistical and Data Center, Statistics, Buffalo, United States of AmericaMichael Birrer - University of Arkansas Medical CenterBradley Monk - Gynecologic Oncology GroupYingmiao Liu - Duke Cancer InstituteMark Starr - Duke Cancer InstituteChris Brady - Duke Cancer InstituteMario Leitao - Memorial Sloan Kettering Cancer CenterLois Ramondetta - The University of Texas MD Anderson Cancer CenterKiran Clair - University of California, IrvineMeredith Newton - University of North Carolina at Chapel HillSaketh Guntupalli - University of Colorado DenverDebra Richardson - University of Oklahoma Health Sciences CenterPaul Disilvestro - Women & Infants Hospital of Rhode IslandGuillerme Cantuaria - Georgia Center for Oncology Research and Education, Atlanta, United States of AmericaCharles Leath III - University of Alabama at BirminghamCaroline Billingsley - University of CincinnatiMegan Mcdonald - University of IowaJayanthi Lea - The University of Texas Southwestern Medical CenterFrederick Ueland - University of KentuckyLaura Chambers - The Ohio State UniversityKrishnansu S. Tewari - University of California, IrvineAndrew Nixon - Duke Cancer Institute
- Resource Type
- Abstract
- Publication Details
- International journal of gynecological cancer, Vol.35(11 Suppl 1), p.102158
- DOI
- 10.1016/j.ijgc.2025.102158
- ISSN
- 1048-891X
- eISSN
- 1525-1438
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 11/2025
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9985027460002771
Abstract
PREDICTIVE BLOOD-BASED BIOMARKERS IN CERVICAL CANCER PATIENTS TREATED WITH PACLITAXEL-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: RESULTS FROM GOG-0240
International journal of gynecological cancer, Vol.35(11 Suppl 1), p.102158
11/2025
DOI: 10.1016/j.ijgc.2025.102158
Details
Metrics
5 Record Views